These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 17047598

  • 1. [Ivabradine--the first selective and specific I(f) inhibitor, novel preparation for treatment of stable angina].
    Belousov IuB, Erofeeva SB, Maneshina OA.
    Kardiologiia; 2006; 46(8):36-48. PubMed ID: 17047598
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
    Fox K.
    Expert Opin Pharmacother; 2006 Jun; 7(9):1211-20. PubMed ID: 16732707
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
    Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Study Investigators.
    Eur Heart J; 2009 Mar; 30(5):540-8. PubMed ID: 19136486
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS, Le Heuzey JY.
    Am J Ther; 2008 Mar; 15(5):461-73. PubMed ID: 18806523
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D, Camm JA.
    Drugs; 2004 Mar; 64(16):1757-65. PubMed ID: 15301560
    [Abstract] [Full Text] [Related]

  • 10. Ivabradine: an intelligent drug for the treatment of ischemic heart disease.
    Riccioni G.
    Molecules; 2012 Nov 16; 17(11):13592-604. PubMed ID: 23159921
    [Abstract] [Full Text] [Related]

  • 11. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A, Tardif JC.
    Adv Cardiol; 2006 Nov 16; 43():65-78. PubMed ID: 16936473
    [Abstract] [Full Text] [Related]

  • 12. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
    Prasad UK, Gray D, Purcell H.
    Adv Ther; 2009 Feb 16; 26(2):127-37. PubMed ID: 19259630
    [Abstract] [Full Text] [Related]

  • 13. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W, Tendera M, Ford I, Fox KM.
    Drugs; 2007 Feb 16; 67(3):393-405. PubMed ID: 17335297
    [Abstract] [Full Text] [Related]

  • 14. Novel If current inhibitor ivabradine: safety considerations.
    Savelieva I, Camm AJ.
    Adv Cardiol; 2006 Feb 16; 43():79-96. PubMed ID: 16936474
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
    Borer JS, Tardif JC.
    Am J Cardiol; 2010 Jan 01; 105(1):29-35. PubMed ID: 20102886
    [Abstract] [Full Text] [Related]

  • 16. Ivabradine: pharmacodynamic aspects of its clinical use.
    Stieber J.
    Methods Find Exp Clin Pharmacol; 2008 Oct 01; 30(8):633-41. PubMed ID: 19088948
    [Abstract] [Full Text] [Related]

  • 17. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A, de Silva R.
    Cardiovasc Drugs Ther; 2016 Aug 01; 30(4):407-417. PubMed ID: 27475447
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.